The overall response rate and median survival between PD-L1 positive and negative groups across all cancer stages

PD-L1 positive (n = 12)PD-L1 negative (n = 22)P value
Received treatment10 (83%)16 (73%)
Response rates to treatment8 (80%)11 (67%)0.67
Median overall survival (mo.)11.570.34